Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Glassman

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Prevention Science : the Official Journal of the Society for Prevention Research|August 22, 2022
Who Benefits from School-Based Teen Pregnancy Prevention Programs? Examining Multidimensional Moderators of Program Effectiveness Across Four StudiesSara A Vasilenko, Omolola A Odejimi, Jill R Glassman, et al.
Ophthalmology|March 4, 2016
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical TrialJohn A Wells, Adam R Glassman, Allison R Ayala, et al.
Ophthalmology|February 9, 2024
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40Chirag D Jhaveri, Danni Liu, Maureen G Maguire, et al.
JAMA|December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical TrialAndrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
Progress in Community Health Partnerships : Research, Education, and Action|February 2, 2026
Building a Learning Community for Inclusive Authorship in Scholarly Writing and PublishingKaren D Calhoun, Chioma Nnaji, Suzanne M Dolwick Grieb, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
IL-2-induced Stat3 Signaling is Critical for Effector Treg Cell ProgrammingEmma C Dean, Daniel F Ditoro, Duy Pham, et al.
Cell|July 2, 2026
A viral ORFeome library for systems-level genetic dissection of host-pathogen interactionsEric Fujimura, Colin N O'Leary, Mamie Z Li, et al.
Cell|March 24, 2022
Facile discovery of surrogate cytokine agonistsMichelle Yen, Junming Ren, Qingxiang Liu, et al.
Ophthalmology|March 20, 2010
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction, Julia A Haller, Haijing Qin, et al.
JAMA|May 1, 2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical TrialCarl W Baker, Adam R Glassman, Wesley T Beaulieu, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Prevention Science : the Official Journal of the Society for Prevention Research|August 22, 2022
Who Benefits from School-Based Teen Pregnancy Prevention Programs? Examining Multidimensional Moderators of Program Effectiveness Across Four StudiesSara A Vasilenko, Omolola A Odejimi, Jill R Glassman, et al.
Ophthalmology|March 4, 2016
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical TrialJohn A Wells, Adam R Glassman, Allison R Ayala, et al.
Ophthalmology|February 9, 2024
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40Chirag D Jhaveri, Danni Liu, Maureen G Maguire, et al.
JAMA|December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical TrialAndrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
Progress in Community Health Partnerships : Research, Education, and Action|February 2, 2026
Building a Learning Community for Inclusive Authorship in Scholarly Writing and PublishingKaren D Calhoun, Chioma Nnaji, Suzanne M Dolwick Grieb, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
IL-2-induced Stat3 Signaling is Critical for Effector Treg Cell ProgrammingEmma C Dean, Daniel F Ditoro, Duy Pham, et al.
Cell|July 2, 2026
A viral ORFeome library for systems-level genetic dissection of host-pathogen interactionsEric Fujimura, Colin N O'Leary, Mamie Z Li, et al.
Cell|March 24, 2022
Facile discovery of surrogate cytokine agonistsMichelle Yen, Junming Ren, Qingxiang Liu, et al.
Ophthalmology|March 20, 2010
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction, Julia A Haller, Haijing Qin, et al.
JAMA|May 1, 2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical TrialCarl W Baker, Adam R Glassman, Wesley T Beaulieu, et al.
Pageof 23